Navigation Links
St. Jude discovery offers new avenues to understanding an aggressive form of leukemia
Date:4/14/2008

Researchers at St. Jude Childrens Research Hospital have discovered evidence that a series of genetic mutations work together to initiate most cases of an aggressive and often-fatal form of acute lymphoblastic leukemia (ALL).

These defects, known as "cooperating oncogenic lesions," include the deletion of a gene, IKZF1, whose protein, Ikaros, normally helps guide the development of a blood stem cell into a lymphocyte. The researchers also found that loss of the same gene accompanied the transformation of chronic myelogenous leukemias (CMLs) to a life-threatening acute stage.

"These findings provide new avenues to pursue to gain a better understanding of these disease processes and, ultimately, to develop better therapies," said James R. Downing, M.D., St. Jude scientific director and chair of the Department of Pathology.

The new study, which he and his colleagues reported in the advance online publication of the journal "Nature," adds further support to a key concept in cancer genetics: Malignancies frequently require mutations in multiple genes in order to develop.

Cells contain oncogenes, which exist harmlessly until something triggers them to turn the cells malignant.

"It really takes a series of genetic lesions to lead to cancer," Downing said. "You may get activation of an oncogene, but you may also need activation of a tumor suppressor gene and an alteration in a cell-death pathway."

St. Jude researchers sought to identify genetic differences between CML and a form of acute leukemia known as BCR-ABL1{positive ALL.

Both diseases are characterized by the Philadelphia chromosome, which results from the translocation (joining) of parts of two different chromosomes. The result of this translocation is the expression of BCR-ABL1, an oncogene.

"It appears from our study, and other work published previously, that all you need to get CML is that chromosomal translocation and BCR-ABL1 expression," Downing said.

In their new study, the researchers re-examined the genetic makeup of 304 ALL patients who had been studied earlier. The group included 43 pediatric and adult BCR-ABL1 ALL patients and 23 adults with CML. Using a more sensitive technology, the scientists increased the number of genetic mutations found in their original gene survey.

In the first study, the gene most commonly altered was one called PAX5, followed by a gene designated IKZF1. Its protein, Ikaros, is involved in the development and differentiation of B lymphocyte cells, which are part of the immune system.

"The vast majority of pediatric acute lymphoblastic leukemias are of B-cell lineage," Downing said.

Among the ALL patients, the researchers found an average of 8.79 copy number alterations, a form of genetic change linked to the development and progression of cancer. The most common change was deletion of the gene for Ikaros.

The gene was deleted in 36 (83.7 percent) of the BCR-ABL1 ALL patients, including 76.2 percent of the pediatric and 90.9 percent of the adult cases.

"The loss of the Ikaros gene is a nearly obligatory lesion for the development of BCR-ABL1 ALL," Downing said, "and clearly must be a genetic lesion that is cooperating with BCR-ABL1."

Moreover, a gene known as CDKN2A was deleted in 53.5 percent of the BCR-ABL1 ALL patients, 87.5 percent of whom also had lost the gene for Ikaros. The PAX5 deletion occurred in 51 percent of the BCR-ABL1 ALL patients; and 95 percent of these people were missing the Ikaros gene.

Among the CML patients whose disease converted to ALL, two out of three had the deletion of the Ikaros gene; a lower percentage of those who converted to acute myeloblastic leukemia had the same gene deleted. That finding suggested that the deletion of Ikaros is cooperating with BCR-ABL1 to cause ALL.

"That is an important finding that may give insight into how that transformation occurs, or it may give insight into a better way to treat the disease, if one can figure out how the Ikaros deletion is working," Downing said.


'/>"/>

Contact: Carrie Strehlau
media@stjude.org
901-495-2295
St. Jude Children's Research Hospital
Source:Eurekalert

Related medicine news :

1. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
2. Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS
3. Mitosis gets harder thanks to new gene discovery
4. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
5. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
6. Baby Madness is Sweeping the Nation! Forty Sets of Twins and Triplets Hit the Court in Discovery Healths BABY MADNESS: MULTIPLES
7. Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment
8. New protein discovery helps researchers understand autoimmune diseases
9. Specialists in drug discovery and development convene
10. Keystone Programs for Collaborative Discovery Launch at Fox Chase
11. Natural Products Discovery and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... ... part of a larger group investing in InsightRX, an early stage company in ... underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... designs created specifically for use in Final Cut Pro X. The business-oriented elements ... productions. Pixel Film Studios’ ProParagraph Corporate will deliver a professional and distinguished look ...
(Date:5/21/2017)... , ... May 21, 2017 , ... For more than ... cover a wide range of knives and swords, from functional to fantasy. United Cutlery ... goods with sleek, modern designs that defy tradition. , Offering a range of weapons ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader in higher education ... began recruitment efforts for the inaugural cohort of its online Master of ... expertise to approach and address the unique nuances healthcare organizations face using a ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Hill Agencies, a family managed firm that ... California Central Valley, is announcing a joint charity initiative with the Boys and Girls ... kid’s camp event. , The Boys and Girls Club of Kern County gives young ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)... 2017 A Catheterization Laboratory is an ... facility. Commonly referred to as cath lab, this ... imaging technology to give physicians visual access to ... spaces, a team of physicians perform life-saving procedures ... intervention, congenital heart defect closure, stenotic heart valves, ...
(Date:5/3/2017)... N.J. , May 3, 2017  Getinge, ... that contribute to quality enhancement and cost efficiency ... from a study of contemporary practice demonstrating that ... first-line therapy for critically ill patients. The single-center, ... Company,s newer large volume MEGA ® 50cc ...
(Date:5/2/2017)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... European Med Tech Reimbursement Consulting AB that allows ... Reimbursement Consulting AB,s proprietary market analyses through the MarketResearch.com ... around the world easy access to complete product descriptions ...
Breaking Medicine Technology: